# Evaluation of the Effect of Adding Dexamethasone to 2% Lidocaine

> **NCT05361291** · NA · COMPLETED · sponsor: **Jamia Millia Islamia** · enrollment: 124 (actual)

## Conditions studied

- Pulpitis - Irreversible

## Interventions

- **DRUG:** Lidocaine Hydrochloride

## Key facts

- **NCT ID:** NCT05361291
- **Lead sponsor:** Jamia Millia Islamia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-01
- **Primary completion:** 2021-08-25
- **Final completion:** 2021-08-25
- **Target enrollment:** 124 (ACTUAL)
- **Last updated:** 2022-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05361291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05361291, "Evaluation of the Effect of Adding Dexamethasone to 2% Lidocaine". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT05361291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*